Researchers at home may drive forward pharmaceutical innovation

Laboratory products

Researchers at home may drive forward pharmaceutical innovation

27 Apr, 2012

Published over 14 years ago. See the latest and most current information on Laboratory products.

A team of researchers from Glasgow University have built what they call ‘reactionware’, enabling novel techniques in 3D printing technology to simplify the production of drugs.

The new system could lead to home design and synthesis of pharmaceuticals, with basements and bedrooms being turned into the laboratories of the future.

Reactionware are “special vessels for chemical reactions which are made from a polymer gel”, the researchers explain. These will replace traditional laboratory vessels such as beakers, because they both house the chemical reaction and are part of the chemical reaction itself. The process becomes much more simple, with researchers simply adding chemicals to the polymer gel and then 3D printing it into the matrix.

Professor Lee Cronin, Chair of Chemistry at the University of Glasgow said: “It’s a new way for chemists to think, and it gives us very specific control over reactions because we can continually refine the design of our vessels as required."

Reactionware could signal a new era for research scientists and business as it allows them the ability to create novel industrial products, such and detergents and pigments, as well as opening the door to personalised chemical products, such as medicines.

Posted by Ben Evans

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Precision by weight: The critical role of gravimetric blending in fuel certification
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow